Status:
UNKNOWN
Kinetic of Immune Memory Response After Re-Vaccination With Meningococcal Vaccine
Lead Sponsor:
Chiron Corporation
Conditions:
Meningococcal Disease; Meningococcal Meningitis
Eligibility:
All Genders
13-15 years
Phase:
PHASE4
Brief Summary
The purpose of this study is to determine when a memory immune response after re-vaccination with Meningococcal C conjugate vaccine (Menjugate) or challenge with Meningococcal A/C polysaccharide vacci...
Eligibility Criteria
Inclusion
- Healthy adolescents between and including 13-15 years of age, who provide written informed consent and who received one immunization with Chiron Meningococcal C Conjugate vaccine (Menjugate) during the UK immunization campaign and for which documentation can be provided.
Exclusion
- Subjects with a previous or suspected disease caused by N. meningitidis; or previous immunization with a meningococcal vaccine or vaccine containing meningococcal antigen(s); Any serious acute, chronic or progressive disease
Key Trial Info
Start Date :
September 1 2003
Trial Type :
INTERVENTIONAL
End Date :
Estimated Enrollment :
264 Patients enrolled
Trial Details
Trial ID
NCT00262015
Start Date
September 1 2003
Last Update
December 6 2005
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Oxford, The Oxford Vaccine Group
Oxford, United Kingdom, OX3 9DU